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Objectives: There have been three eras in the develop-
ment of EVAR: physician-made and early industry devices,
intermediary commercial endografts, and modern sten-
tgrafts. This study analyzed the differences in outcomes
between these three groups.
Methods: From 1992-2012, 1290 patients under-
went elective EVAR. Fifteen different devices were used
during this time. The three eras were deﬁned as: Era1:
1992-96; Era2: 1997-2006; Era3: 2007-2012. Grafts
used in each era were: Era1: physician-made and EVT;
Era2: Talent, Aneurx, Excluder, Quantum LP, Zenith,
Vangaurd, PG AAA, Ancure, Endologix, and Teramed;
Era3: Talent, Aneurx, Endurant, Excluder, Zenith, and
Aptus.
Results: Mean age was 75.2 years and 85% were
men. First generation patients were higher surgical risk
(Mean Glasgow Aneurysm Scores: Era1 84.81 vs Era3:
79.95, P ¼ .048). Adjunctive procedures increased
from Era1 to Era3 (P ¼ .014). Procedure times (P <
.001), Blood loss (P ¼ .01), and Length of stay (P <
.001) have declined overtime. Major peri-operative
complications (Era1: 23%, Era2: 9.2%, and Era3: 4.5%;
P < .001) and AAA-related peri-operative mortality
(Era1: 17.6%, Era2: 2.3%, and Era3: 0.0%; P < .001)Fig.have decreased. Type 1 and 3 endoleaks (P ¼ .011)
and the need for reintervention (P < .001) have dimin-
ished. Median survival for all causes of death and
freedom from aneurysm-related mortality signiﬁcantly
improved (Fig).
Conclusions: EVAR has evolved over the last 20 years
resulting in an overall improvement in efﬁciency, outcomes
and procedural success.
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Objectives: To determine predictors of conversion
from percutaneous (PEVAR) to an open approach
(OEVAR) during groin access of endovascular aortic aneu-
rysm repair (EVAR).
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from January 2009 through June 2011. Target vessels were
classiﬁed as mild (<1/3), moderate (1/3 to ½) or severe
(>½) according to circumference of calciﬁcation.
Results: We investigated 400 access sites for 200
patients who underwent EVAR. Averages were age 72.8
+ 9.0, vessel size 9.6 + 1.8, sheath size 17.1 + 3.0, BMI
27.6 + 5.3, and eGFR 68.5 + 24.2%. Co-morbidities
included dyslipidemia (64.5%), and hypertension (42.0%).
There were 132 OEVAR (66 patients), 2 mixed (OEVAR
and PEVAR for 1 patient) and 266 (133 patients) PEVAR
approaches. Use of PEVAR increased over time [45.5%
(2009), 77.8% (2010) and up to 88.5% (2011); P ¼
.001] while conversion decreased [24.3% (2009), 8.7%
(2010) and 4.3% (2011); P ¼ .001]. Length of stay was
signiﬁcantly shorter for PEVAR (3.0 + 4.6 vs 6.1 + 9.1
days; P ¼ .013). For the 266 PEVAR approaches, 32
(32/266 ¼ 12.0%) had to be converted. After multivariate
analysis, it was found that severely calciﬁed arteries were
most predictive of conversion (odds ratio (OR), 36.4;
P < .001). Year of procedure (2010; OR, 0.17; P ¼
.001), (2011; OR, 0.20; P ¼ .049), female gender (OR,
3.1; P ¼ .017), moderately calciﬁed arteries (OR, 2.5;
P ¼ .085) and age (OR, 2.3 (per decade); P ¼ .002)
were all also signiﬁcant. Vessel and sheath size along with
BMI were non-signiﬁcant.
Conclusions: PEVAR was found to be safe, reliable
and feasible. Several factors including vessel calciﬁcation,
age and female gender should be considered before
PEVAR intervention.
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Objectives: To determine anatomic and plaque-related
risk factors for patients undergoing carotid artery stenting.
Methods: A retrospective review of patients in
a prospectively maintained database undergoing carotid
artery stenting at our institution between 2001-10 was
performed. Preoperative imaging studies (ie, ultrasound,
CTA, MRA, and angiograms) were reviewed for
speciﬁc anatomic criteria and plaque characteristics.
Primary outcomes included perioperative neurologic
events (30-day CVA or TIA), 30-day mortality,
CVA, and MI. Secondary outcome included stent
restenosis.Results: Imaging was reviewed for 408 carotid
arteries in 382 patients. There were 15 perioperative
neurologic events (3.6%), with eight TIA, ﬁve CVA,
and two seizures. 30-day mortality, CVA, and MI
was 0.5%, 2.0%, and 0.7%, respectively. Surprisingly,
we found that arch type (I ¼ 32%; II ¼ 60%; III ¼
7%), ostial involvement (12%), tandem lesions (20%),
and plaque calciﬁcation (78%) did not correlate with
perioperative neurologic events. Arch calciﬁcation was
more common in female vs male patients (mild,
53.1% vs 66.5%; moderate, 32.3% vs 26.5%; severe,
14.6% vs 7.1%; P ¼ .05), but did not correlate with
perioperative events. CCA tortuosity was more
common in octogenarians (80% vs 27.5%; P ¼ .02),
but did not correlate with perioperative events. Ipsilat-
eral ECA stenosis >50% did correlate with periopera-
tive neurologic events (8.2% vs 2.3%; P ¼ .04).
Plaque ulceration was present in 55% of patients, and
trended towards an increase in neurologic events (P
¼ .07). In terms of secondary criteria, a lower ICA
to CCA angulation was associated with restenosis (P
¼ .03), and more steeply angulated arch types trended
towards an increase in restenosis (I ¼ 1.1%; II ¼ 2.5%;
III ¼ 10.5%; P ¼ .09).
Conclusions: Our data suggest that ipsilateral ECA
stenosis and plaque ulceration may be associated with
increased perioperative neurologic risk during carotid stent-
ing, but surprisingly, arch type and calciﬁcation are not.
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Objectives: To evaluate transient and persistent
cranial nerve palsy (CNP) after carotid endarterectomy
(CEA), the nerves affected and predictors for CNP.
Methods: All CEA patients in the Vascular Study
Group of New England were identiﬁed between 2003-
2011. Primary endpoints were CNP at discharge and
persistent CNP at follow-up (median 1 year). Hierarchical
multivariable model controlling for surgeon and hospital
was used to assess independent predictors.
Results: 6878 patients (33.8% symptomatic) were
included for analyses. 1.3% of patients had prior cervical
radiation and 2.2% of patients underwent redo-CEA.
CNP rate at discharge was 5.6% (n ¼ 382). Sixty patients
(0.7%) had more than 1 branch affected. The hypoglossal
nerve (XII) was most frequently involved (n ¼ 185,
